ABSTRACT
INTRODUCTION
If DNA diagnostics are to become as widely used and as reliable as immunoassays, new techniques for nucleic acid isolation must be developed. This requirement is particularly acute for amplification-based diagnostics because of the presence in clinical specimens of inhibitors of DNA polymerases. Heparin (1) and heme (10, 13) are frequently encountered in clinical extracts. Glycoproteins (24) and high concentrations of albumin (20) can be inhibitory. Nonhomologous DNA can also reduce the efficiency of polymerase chain reaction (PCR). This sort of inhibition is typically reversible through the use of hot-start protocols (5) . Efficiency of PCR is monitored through the use of internal standards but at higher assay cost. A better approach to the inhibitor problem is to avoid copurifying them with the DNA or RNA to be amplified.
Nucleic acids can be extracted and amplified from a crude lysate (9) . More commonly, they are purified by such techniques as organic extraction (e.g., acid guanidinium phenol; Reference 4), silica binding (2) , salt precipitation (14) or cationic detergents (6) . Total mRNA is typically purified by capture of all poly(A) sequences on solid phases containing poly(dT) (11) . Immunoaffinity reagents have been used to capture intact viral particles prior to conventional extraction (3) . A few reports have described the purification of specific mRNAs or viral nucleic acids by probe capture (15, 19) , demonstrating the feasibility of using hybridization as an affinity purification technique for nucleic acids.
Recently, nonionic polymers for sequence-specific binding to nucleic acids have been described (peptide nucleic acids [PNA; References 16 and 17] and morpholino oligonucleotides [Neu-Probes ™; AntiVirals, Corvallis, OR, USA; References 12 and 18]). Such molecules have unique properties as hybridization probes, including the ability to hybridize independently of ionic strength and essentially complete resistance to nucleases. We compare three formats for RNA purification by hybridization-based capture using uncharged morpholino probes.
MATERIALS AND METHODS

RNA Transcripts
RNA transcripts were prepared using the MEGAscript ™ T7 Kit (Ambion, Austin, TX, USA) following the manufacturer's recommended procedure. Initial experiments used a 550-nucleotide (nt) transcript from human immunodeficiency virus (HIV) gag (pBENN7; Reference 7), and experiments with multiple specific-capture probes used a 750-nt RNA. Also, a nonhomologous RNA of similar size was prepared that contained sequences of rabbit α -globin. Unincorporated nucleotides were removed using two passes through ProbeQuant ™G-50 Micro Columns (Pharmacia Biotech, Piscataway, NJ, USA), followed by lithium chloride precipitation. Poly(A) polymerase (Life Technologies, Gaithersburg, MD, USA) was used to add a poly(A) tail. Integrity of the transcripts and approximate tail lengths (at least 100 nt, by comparison with RNA standards) were monitored by electrophoresis on 4% polyacrylamide/7 M urea gels.
Lysates of normal human plasma were prepared with 3 vol of PUREscript ® Cell Lysis Solution (Gentra Systems, Minneapolis, MN, USA), which were first titrated to pH 7.5 with 10 NNaOH. RNA (10 4 counts per minute [cpm]; alternatively, 10 4 copies in experiments using a PCR endpoint) was then added to the plasma lysate (50 µ L plasma + 150 µ L lysis solution). All experiments (except that for which results are described in the legend to Figure 1 ) used an RNA-spiked plasma lysate. For capture by any of the formats described in this report, 100 µ g of streptavidin-coated 2.8-µ m M-280 Superparamagnetic Dynabeads ® (Dynal, Lake Success, NY, USA) and incubation at 37°C with constant shaking for 30 min were used. Capture particles were magnetically separated using a magnetic particle concentrator (MPC ® -E; Dynal) and washed three times with RNase-free water. For particles containing U 25 and a cleavable linker, beads were washed with 50 mM dithiothreitol (DTT).
Capture Probes
HIV sequence-specific probes (antisense) were designed to bind upstream of the SK 462 primer sequence (23) , thus outside the region targeted for amplification. Morpholino capture probes were synthesized with 5 ′ biotin and a long spacer (polyethylene glycol [PEG]-3400; Shearwater Polymers, Huntsville, AL, USA) between biotin and the probe sequence. The quality of each oligonucleotide following HPLC purification was assessed by matrix-assisted laser desorption ionization mass spectroscopy with time of flight analyzer (MALDI-TOF). Stock solutions (1 mM) in RNase-free water were stored at 4°C. The probe sequences were as follows (HIV sequence positions refer to the HXB2 isolate, whose sequence was obtained from the Los Alamos HIV sequence database): mo (U) 25 : 5 ′ -biotin-S-S-PEG-mo (U) 25 ; HIV-CP1: 5 ′ -biotin-PEG-mo (UUUAAAUCUUGUGGGGUGGCUCC) (nt 1342-1320); HIV-CP2: 5 ′ -biotin-PEG-mo (GAAAACAU-GGGUAUCACUUCUGGGC) (nt 1306-1282); HIV-CP3: 5 ′ -biotin-PEG-mo (UGCGAAUCGUUCUAGCUCCCUG) (nt 923-902).
Capture Formats and Particles
Three hybridization capture formats were evaluated. Direct capture used particles previously saturated with probes, following the manufacturer's suggested protocol for coating the particles, but using 0.6 pmol probe/ µ g particles to ensure maximal coating. No direct assessment of probe loading was made, and the possibility exists that binding capacity of M-280 for DNA oligonucleotides is different from uncharged morpholino oligonucleotides of similar lengths. Higher binding capacities for biotinylated morpholino oligonucleotides, for example, would result in particles showing a higher efficiency of capture of complementary sequences.
A third capture format, which we designated the multipleprobe capture system, exploits the rapid kinetics of capture by poly(U) to give an acceleration of hybridization to sequencespecific probes bound to the same particles. Polyadenylated RNA bound only through the poly(U) sequence is released through a cleavable disulfide linker using DTT, leaving only specifically hybridized RNA bound to the particle. Particles were coated with U 25 and either HIV-CP1 or an equimolar mixture of HIV-CP1, -CP2 and -CP3. M-280 particles bearing no capture probes were found to not capture appreciable amounts of HIV RNA under these conditions (data not shown). Using radiolabeled, nonhomologous RNA, beads carrying only HIV-specific probes were found to capture ≤ 2% of applied cpm (data not shown).
PCR Methods
For assessment of capture of RNA at low copy number, reverse transcription (RT)-PCR was performed by standard methods using 30 cycles and 0.2 µ M each of primers SK 462 and 5 ′ -biotin SK 431 (Reference 23; BioSource, Camarillo, CA, USA). For PCR product analysis, an affinity-based hybrid capture assay (22) was used with fluorescence detection of alkaline phosphatase using 4-methylumbelliferyl phosphate. Typically, 100 copies of RNA could be detected by these methods, and 100-10 4 copies covered the exponential phase of PCR. 
RESULTS
Capture in Low-Salt Solution
The efficiencies of capture by dT 25 (Dynal) and morpholino U 25 were compared in high-salt and low-salt hybridization buffers. Figure 1 indicates that efficient capture was obtained within 1 min in high-salt buffer, using either DNA or morpholino capture oligonucleotides. Morpholino U 25 , in contrast to dT 25 , was also able to hybridize at low ionic strength. Since experiments (Wages, unpublished) show that morpholino probes hybridize to DNA targets with kinetics that are not dependent on salt concentration, we attribute this somewhat slower binding at very low ionic strength to an effect on the particles rather than the probes. Successful hybridization in 1 mM EDTA demonstrates the potential for hybridization at low ionic strength where nucleic acid secondary structures are expected to be destabilized.
Co-Purification of Inhibitors
To assess co-purification of inhibitors by various RNA purification techniques, plasma was spiked with high levels of heme or heparin. As shown in Figure 2 , only hybridizationbased purification avoids co-purifying these inhibitors.
Multiple-Probe Capture System
Initial experiments (21) with a single specific-capture probe and U 25 gave selective retention of HIV RNA but low recovery (37%). In separate experiments with RNA bound to particles having only HIV-CP1, some loss was observed with heating at 37°C. This suggested that higher recoveries could be obtained using a longer capture probe, a probe with higher T m or multiple-capture probes. Particles were subsequently prepared by coupling probes HIV-CP1, HIV-CP2, HIV-CP3 and U 25 to M-280 Dynabeads. Increased recovery was obtained (51.4%), suggesting that multiple-capture probes facilitate retention of RNA on the particles.
Comparison of Three Capture Formats
Capture and recovery of poly(A) HIV RNA were then compared for the three capture formats. Figure 3 shows that capture and recovery were higher with indirect capture (56%) or the multiple-probe capture system (51%) than with direct capture (6.6%). The presence of multiple specific probes for direct capture resulted in only marginal improvements in capture and recovery. Although multiple probes increased the recovery of direct capture from 0.8% (essentially background) to 6.6%, under no conditions tested did direct capture on M-280 particles approach the efficiency attained with either of the other methods.
DISCUSSION
We present methods for hybridization-based sample preparation for RT-PCR and demonstrate that such techniques avoid co-purification of PCR inhibitors. This suggests that clinical assays will benefit from hybridization-based sample preparation, which will reduce the frequency of false negatives resulting from co-purification of heme or polyanionic polysaccharides. Such techniques may also be useful for the analysis of archival specimens collected using heparin anticoagulant and for the purification of DNA from environmental samples.
The multiple-probe capture system, which uses a rapidly hybridizing, generic probe to accelerate hybridization to sequence-specific probes, was developed as a technique for selective, high-recovery purification of specific polyadenylated sequences. Such a technique might have applications for selecting specific mRNAs from total RNA. Other hybridization accelerants can be envisioned that would use affinity interactions such as dye binding (8) or cationic capture to bring RNA from solution into proximity to specific probes. As long as the affinity reagents do not interfere with hybridization, such approaches appear feasible.
These capture formats should support the use of DNA probes and the novel morpholino oligonucleotides described in this report. Unlike DNA probes, the pairing of uncharged probes to their target sequences is relatively independent of salt concentration. This makes possible capture of targets under conditions that destabilize RNA secondary structure and thereby expose otherwise unavailable target sequences. This property is likely to be advantageous for target RNAs with stable secondary structures, such as rRNA or the untranslated regions of mRNAs. In the case of viruses, such as hepatitis C virus (HCV), the untranslated regions contain some of the most conserved sequences, which are desirable diagnostic targets. Degenerate capture probes may also prove useful for gene or new pathogen discovery research, using probes based on known sequence motifs. Since morpholino oligonucleotides are not extended by polymerases, even high concentrations of unrelated morpholino sequences do not interfere with subsequent PCR.
